Cargando…
Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories
Background and Purpose Three network laboratories measured antibodies to islet autoantigens. Antibodies to glutamic acid decarboxylase (GAD65 [GADA]) and the intracellular portion of protein tyrosine phosphatase (IA-2(ic) [IA-2A]) were measured by similar, but not identical, methods in samples from...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917851/ https://www.ncbi.nlm.nih.gov/pubmed/20693189 http://dx.doi.org/10.1177/1740774510373496 |
_version_ | 1782185090372075520 |
---|---|
author | Bingley, Polly J Williams, Alistair JK Colman, Peter G Gellert, Shane A Eisenbarth, George Yu, Liping Perdue, Letitia H Pierce, June J Hilner, Joan E Nierras, Concepcion Akolkar, Beena Steffes, Michael W |
author_facet | Bingley, Polly J Williams, Alistair JK Colman, Peter G Gellert, Shane A Eisenbarth, George Yu, Liping Perdue, Letitia H Pierce, June J Hilner, Joan E Nierras, Concepcion Akolkar, Beena Steffes, Michael W |
author_sort | Bingley, Polly J |
collection | PubMed |
description | Background and Purpose Three network laboratories measured antibodies to islet autoantigens. Antibodies to glutamic acid decarboxylase (GAD65 [GADA]) and the intracellular portion of protein tyrosine phosphatase (IA-2(ic) [IA-2A]) were measured by similar, but not identical, methods in samples from participants in the Type 1 Diabetes Genetics Consortium (T1DGC). Methods All laboratories used radiobinding assays to detect antibodies to in vitro transcribed and translated antigen, but with different local standards, calibrated against the World Health Organization (WHO) reference reagent. Using a common method to calculate WHO units/mL, we compared results reported on samples included in the Diabetes Autoantibody Standardization Program (DASP), and developed standard methods for reporting in WHO units/mL. We evaluated intra-assay and inter-assay coefficient of variation (CV) in blind duplicate samples and assay comparability in four DASP workshops. Results Values were linearly related in the three laboratories for both GADA and IA-2A, and intra-assay technical errors for values within the standard curve were below 13% for GADA and below 8.5% for IA-2A. Correlations in samples tested 1–2 years apart were >97%. Over the course of the study, internal CVs were 10–20% with one exception, and the laboratories concordantly called samples GADA or IA-2A positive or negative in 96.7% and 99.6% of duplicates within the standard curve. Despite acceptable CVs and general concordance in ranking samples, the laboratories differed markedly in absolute values for GADA and IA-2A reported in WHO units/mL in DASP over a large range of values. Limitations With three laboratories using different assay methods (including calibrators), consistent values among them could not be attained. Conclusions Modifications in the assays are needed to improve comparability of results expressed as WHO units/mL across laboratories. It will be essential to retain high intra- and inter-assay precision, sensitivity and specificity and to confirm the accuracy of harmonized methods. |
format | Text |
id | pubmed-2917851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-29178512010-08-13 Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories Bingley, Polly J Williams, Alistair JK Colman, Peter G Gellert, Shane A Eisenbarth, George Yu, Liping Perdue, Letitia H Pierce, June J Hilner, Joan E Nierras, Concepcion Akolkar, Beena Steffes, Michael W Clin Trials Articles Background and Purpose Three network laboratories measured antibodies to islet autoantigens. Antibodies to glutamic acid decarboxylase (GAD65 [GADA]) and the intracellular portion of protein tyrosine phosphatase (IA-2(ic) [IA-2A]) were measured by similar, but not identical, methods in samples from participants in the Type 1 Diabetes Genetics Consortium (T1DGC). Methods All laboratories used radiobinding assays to detect antibodies to in vitro transcribed and translated antigen, but with different local standards, calibrated against the World Health Organization (WHO) reference reagent. Using a common method to calculate WHO units/mL, we compared results reported on samples included in the Diabetes Autoantibody Standardization Program (DASP), and developed standard methods for reporting in WHO units/mL. We evaluated intra-assay and inter-assay coefficient of variation (CV) in blind duplicate samples and assay comparability in four DASP workshops. Results Values were linearly related in the three laboratories for both GADA and IA-2A, and intra-assay technical errors for values within the standard curve were below 13% for GADA and below 8.5% for IA-2A. Correlations in samples tested 1–2 years apart were >97%. Over the course of the study, internal CVs were 10–20% with one exception, and the laboratories concordantly called samples GADA or IA-2A positive or negative in 96.7% and 99.6% of duplicates within the standard curve. Despite acceptable CVs and general concordance in ranking samples, the laboratories differed markedly in absolute values for GADA and IA-2A reported in WHO units/mL in DASP over a large range of values. Limitations With three laboratories using different assay methods (including calibrators), consistent values among them could not be attained. Conclusions Modifications in the assays are needed to improve comparability of results expressed as WHO units/mL across laboratories. It will be essential to retain high intra- and inter-assay precision, sensitivity and specificity and to confirm the accuracy of harmonized methods. SAGE Publications 2010-08 /pmc/articles/PMC2917851/ /pubmed/20693189 http://dx.doi.org/10.1177/1740774510373496 Text en © The Author(s), 2010 http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Bingley, Polly J Williams, Alistair JK Colman, Peter G Gellert, Shane A Eisenbarth, George Yu, Liping Perdue, Letitia H Pierce, June J Hilner, Joan E Nierras, Concepcion Akolkar, Beena Steffes, Michael W Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories |
title | Measurement of islet cell antibodies in the Type 1 Diabetes Genetics
Consortium: efforts to harmonize procedures among the
laboratories |
title_full | Measurement of islet cell antibodies in the Type 1 Diabetes Genetics
Consortium: efforts to harmonize procedures among the
laboratories |
title_fullStr | Measurement of islet cell antibodies in the Type 1 Diabetes Genetics
Consortium: efforts to harmonize procedures among the
laboratories |
title_full_unstemmed | Measurement of islet cell antibodies in the Type 1 Diabetes Genetics
Consortium: efforts to harmonize procedures among the
laboratories |
title_short | Measurement of islet cell antibodies in the Type 1 Diabetes Genetics
Consortium: efforts to harmonize procedures among the
laboratories |
title_sort | measurement of islet cell antibodies in the type 1 diabetes genetics
consortium: efforts to harmonize procedures among the
laboratories |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917851/ https://www.ncbi.nlm.nih.gov/pubmed/20693189 http://dx.doi.org/10.1177/1740774510373496 |
work_keys_str_mv | AT bingleypollyj measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT williamsalistairjk measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT colmanpeterg measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT gellertshanea measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT eisenbarthgeorge measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT yuliping measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT perdueletitiah measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT piercejunej measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT hilnerjoane measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT nierrasconcepcion measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT akolkarbeena measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT steffesmichaelw measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories AT measurementofisletcellantibodiesinthetype1diabetesgeneticsconsortiumeffortstoharmonizeproceduresamongthelaboratories |